featured
Risk of Immune-Mediated Inflammatory Diseases in Patients With IBD Receiving TNF Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
Clin. Gastroenterol. Hepatol. 2024 Jan 01;22(1)135-143.e8, D Ward, N Nyboe Andersen, S Gørtz, A Thorn Iversen, K Højgaard Allin, L Beaugerie, J Kirchgesner, T JessFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.